A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 39/00 (2006.01)
Patent
CA 2702586
The invention relates to compositions, kits, and methods for cancer prophylaxis and therapy using recombinant MVA viruses encoding tumor-associated antigens, such as PSA and PAP. The recombinant MVA viruses can induce B- and T-cell responses. The recombinant MVA viruses can be administered prior to, at the same time as, or after a taxane.
L'invention porte sur des compositions, des coffrets et des procédés pour une prophylaxie et une thérapie du cancer à l'aide de virus MVA recombinants codant pour des antigènes associés à la tumeur, tels que PSA et PAP. Les virus MVA recombinants peuvent induire des réponses des lymphocytes B et T. Les virus MVA recombinants peuvent être administrés avant, pendant ou après une taxane.
Delcayre Alain
Laus Reiner
Legrand Fatema
Mandl Stefanie
Rountree Ryan Blair
Bn Immunotherapeutics Inc.
Smart & Biggar
LandOfFree
Use of mva to treat prostate cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of mva to treat prostate cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of mva to treat prostate cancer will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1453205